Approvals/CIMA-AEMPS/XERAVA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

XERAVA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Paion Pharma Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: e991cfe19b8f869f
Drug Cima Aemps Name: XERAVA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1181312005
Holder Company Name: Paion Pharma Gmbh
Marketing Company Name: Viatris Pharmaceuticals S.L.U.
Holder Company Detail Path: /organization/paion-pharma-gmbh
Authorization Date: 2023-07-31
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 100 MG
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Paion Pharma Gmbh
Company Detail Path: /organization/paion-pharma-gmbh

ERAVACICLINA

100 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 31, 2023

Approval ID

e991cfe19b8f869f

Type

Standard